# A Study of IBI351 in Healthy Subjects

> **NCT05688124** · PHASE1 · COMPLETED · sponsor: **Innovent Biologics (Suzhou) Co. Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** IBI351
- **DRUG:** Esomeprazole

## Key facts

- **NCT ID:** NCT05688124
- **Lead sponsor:** Innovent Biologics (Suzhou) Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-16
- **Primary completion:** 2023-10-16
- **Final completion:** 2023-10-16
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2023-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05688124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05688124, "A Study of IBI351 in Healthy Subjects". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05688124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*